STATUTORY RULES.
1957. No. 64.
REGULATIONS UNDER THE THERAPEUTIC SUBSTANCES ACT 1953.*
I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the Therapeutic Substances Act 1953.
Dated this 26th day of October, 1957.
W. J. Slim
Governor-General.
By His Excellency’s Command,
Minister of State for Health.
Amendments of the Therapeutic Substances Regulations.†
1.—(1.) After regulation 5 of the Therapeutic Substances Regulations the following regulation is inserted:—
Labelling of therapeutic substances imported into Australia.
“5a. Where goods that consist of a controlled therapeutic substance are labelled in accordance with the last preceding regulation, the label shall, for the purposes of section 7 of the Act, contain, in addition to the requirements referred to in that regulation, the words ‘For Therapeutic Use’ in letters of not less than six point type.”.
(2.) The last preceding sub-regulation shall come into operation on the first day of May, 1958.
Remuneration and allowances of members of Committees.
2.—(1.) Regulation 26 of the Therapeutic Substances Regulations is amended—
(a) by omitting from paragraph (a) of sub-regulation (1.) the words “Five pounds five shillings” and inserting in their stead the words “Seven pounds seven shillings”; and
(b) by omitting from paragraph (b) of that sub-regulation the words “Three pounds three shillings” and inserting in their stead the words “Five pounds five shillings”.
(2.) The last preceding sub-regulation shall be deemed to have come into operation on the first day of July, 1957.
* Notified in the Commonwealth Gazette on 7th November, 1957.
† Statutory Rules 1956, No. 4, as amended by Statutory Rules 1956, No. 113.
By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.
5313/57.—Price 3d. 9/17.9.1957.
Overview
The Therapeutic Substances Regulations 1957 were enacted as a legislative instrument under the Therapeutic Substances Act 1953 by the Governor-General in Council. This legislative instrument was introduced to address the need for specific regulations regarding the labelling and remuneration of therapeutic substances within Australia. The problem it sought to resolve was the lack of clear guidelines on the labelling of therapeutic substances, ensuring they were marked appropriately for their intended therapeutic use, and the need to update the remuneration and allowances for members of the committees overseeing these substances. The objective of these regulations was to enhance the safety and efficacy of therapeutic substances by ensuring they are correctly identified and to adjust the financial compensation for committee members in line with the changing economic conditions of the time.
Scope and Application
The Therapeutic Substances Regulations 1957, made under the Therapeutic Substances Act 1953, are applicable to any person or entity involved in the importation and labelling of controlled therapeutic substances in Australia. These regulations extend to all therapeutic substances brought into Australia and require that they comply with specific labelling requirements, such as the inclusion of the phrase 'For Therapeutic Use' in a specified font size. The geographic reach of these regulations is nationwide, as they are made under a Commonwealth Act and apply across all states and territories of Australia. There are no explicit exclusions or exemptions mentioned in the regulations, implying that all imported therapeutic substances must adhere to the stipulated labelling requirements. The regulations also cover the amendment of remuneration and allowances for members of Committees, reflecting the administrative aspect of enforcing these regulations. Subordinate instruments may further extend or restrict the application of these regulations, but the primary document specifies amendments related to labelling and allowances without detailing additional mechanisms of extension or restriction.
Key Provisions
The key provisions of the Statutory Rules of 1957, No. 64, which are regulations under the Therapeutic Substances Act 1953, primarily concern amendments to labelling requirements and the remuneration for committee members. Firstly, regulation 5a mandates that any goods consisting of a controlled therapeutic substance, when labelled, must include the phrase "For Therapeutic Use" in letters of at least six point type (s. 1(1)). This addition to the labelling requirements is intended to clearly indicate the intended use of the substance and comes into effect on the first of May, 1958 (s. 1(2)). Secondly, regulation 26 is amended to increase the remuneration and allowances for members of Committees. Specifically, the allowance from £5 5s to £7 7s for the Chairman, and from £3 3s to £5 5s for other members (s. 2(1)). These changes are deemed to have taken effect on the first of July, 1957 (s. 2(2)).
These regulations impose specific obligations on parties dealing with controlled therapeutic substances and members of relevant committees. For instance, any entity importing or handling controlled therapeutic substances must ensure that their labelling meets the updated requirements as specified in regulation 5a (s. 1(1)). This includes clearly marking the substance as intended for therapeutic use. Similarly, members of the committees involved must adhere to the new remuneration structures as stipulated in regulation 26 (s. 2(1)). Failure to comply with these financial obligations could potentially impact the legality and effectiveness of their committee activities.
The regulations do not explicitly outline specific offences, penalties, or consequences for non-compliance. However, any breaches of the Therapeutic Substances Act 1953 or its regulations could result in legal action under the broader legislative framework. This could potentially include fines, imprisonment, or other penalties as determined by the courts. The severity of these penalties would depend on the nature and extent of the breach, as well as any relevant case law or statutory provisions.